Cargando…
Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus
Several countries in the European Union (EU) and European Economic Area (EEA) established and/or scaled up HIV pre-exposure prophylaxis (PrEP) programmes between 2016 and 2023. Data on PrEP programmes’ performance and effectiveness in reaching those most in need will be needed to assess regional pro...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318945/ https://www.ncbi.nlm.nih.gov/pubmed/37289428 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.23.2200546 |
_version_ | 1785068145821614080 |
---|---|
author | Vanhamel, Jef Wijstma, Eline Deblonde, Jessika Laga, Marie Vuylsteke, Bea Nöstlinger, Christiana Noori, Teymur |
author_facet | Vanhamel, Jef Wijstma, Eline Deblonde, Jessika Laga, Marie Vuylsteke, Bea Nöstlinger, Christiana Noori, Teymur |
author_sort | Vanhamel, Jef |
collection | PubMed |
description | Several countries in the European Union (EU) and European Economic Area (EEA) established and/or scaled up HIV pre-exposure prophylaxis (PrEP) programmes between 2016 and 2023. Data on PrEP programmes’ performance and effectiveness in reaching those most in need will be needed to assess regional progress in the roll-out of PrEP. However, there is a lack of commonly defined indicators for routine monitoring to allow for minimum comparability. We propose a harmonised PrEP monitoring approach for the EU/EEA, based on a systematic and evidence-informed consensus-building process involving a broad and multidisciplinary expert panel. We present a set of indicators, structured along relevant steps of an adapted PrEP care continuum, and offer a prioritisation based on the degree of consensus among the expert panel. We distinguish between ‘core’ indicators deemed essential for any PrEP programme in the EU/EEA, vs ‘supplementary’ and ‘optional’ indicators that provide meaningful data, yet where experts evaluated their feasibility for data collection and reporting as very context-dependent. By combining a standardised approach with strategic opportunities for adaptation and complementary research, this monitoring framework will contribute to assess the impact of PrEP on the HIV epidemic in Europe. |
format | Online Article Text |
id | pubmed-10318945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | European Centre for Disease Prevention and Control (ECDC) |
record_format | MEDLINE/PubMed |
spelling | pubmed-103189452023-07-05 Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus Vanhamel, Jef Wijstma, Eline Deblonde, Jessika Laga, Marie Vuylsteke, Bea Nöstlinger, Christiana Noori, Teymur Euro Surveill Perspective Several countries in the European Union (EU) and European Economic Area (EEA) established and/or scaled up HIV pre-exposure prophylaxis (PrEP) programmes between 2016 and 2023. Data on PrEP programmes’ performance and effectiveness in reaching those most in need will be needed to assess regional progress in the roll-out of PrEP. However, there is a lack of commonly defined indicators for routine monitoring to allow for minimum comparability. We propose a harmonised PrEP monitoring approach for the EU/EEA, based on a systematic and evidence-informed consensus-building process involving a broad and multidisciplinary expert panel. We present a set of indicators, structured along relevant steps of an adapted PrEP care continuum, and offer a prioritisation based on the degree of consensus among the expert panel. We distinguish between ‘core’ indicators deemed essential for any PrEP programme in the EU/EEA, vs ‘supplementary’ and ‘optional’ indicators that provide meaningful data, yet where experts evaluated their feasibility for data collection and reporting as very context-dependent. By combining a standardised approach with strategic opportunities for adaptation and complementary research, this monitoring framework will contribute to assess the impact of PrEP on the HIV epidemic in Europe. European Centre for Disease Prevention and Control (ECDC) 2023-06-08 /pmc/articles/PMC10318945/ /pubmed/37289428 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.23.2200546 Text en This article is copyright of the authors or their affiliated institutions, 2023. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made. |
spellingShingle | Perspective Vanhamel, Jef Wijstma, Eline Deblonde, Jessika Laga, Marie Vuylsteke, Bea Nöstlinger, Christiana Noori, Teymur Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus |
title | Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus |
title_full | Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus |
title_fullStr | Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus |
title_full_unstemmed | Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus |
title_short | Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus |
title_sort | developing evidence-informed indicators to monitor hiv pre-exposure prophylaxis programmes across eu/eea countries: a multi-stakeholder consensus |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318945/ https://www.ncbi.nlm.nih.gov/pubmed/37289428 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.23.2200546 |
work_keys_str_mv | AT vanhameljef developingevidenceinformedindicatorstomonitorhivpreexposureprophylaxisprogrammesacrosseueeacountriesamultistakeholderconsensus AT wijstmaeline developingevidenceinformedindicatorstomonitorhivpreexposureprophylaxisprogrammesacrosseueeacountriesamultistakeholderconsensus AT deblondejessika developingevidenceinformedindicatorstomonitorhivpreexposureprophylaxisprogrammesacrosseueeacountriesamultistakeholderconsensus AT lagamarie developingevidenceinformedindicatorstomonitorhivpreexposureprophylaxisprogrammesacrosseueeacountriesamultistakeholderconsensus AT vuylstekebea developingevidenceinformedindicatorstomonitorhivpreexposureprophylaxisprogrammesacrosseueeacountriesamultistakeholderconsensus AT nostlingerchristiana developingevidenceinformedindicatorstomonitorhivpreexposureprophylaxisprogrammesacrosseueeacountriesamultistakeholderconsensus AT nooriteymur developingevidenceinformedindicatorstomonitorhivpreexposureprophylaxisprogrammesacrosseueeacountriesamultistakeholderconsensus |